Burning mouth syndrome

July 11, 2012

Burning mouth syndrome (BMS) affects over a million Americans. It has no known cause or otherwise it would not be called a syndrome. For example, burning pain in the mouth due to chemotherapy damage to the mouth lining is called oral mucositis. This condition is not related to migraines, but just like with migraines, three times as many women suffer from BMS than men. Some people with BMS have a sensation of having sand in their mouth and itching, in addition to the burning pain. The pain can be very intense and can persist for many months. A recent study by Italian researchers published in the journal Headache examined 53 patients with with BMS and compared them to 51 healthy volunteers. They discovered that patients with BMS were much more likely to have anxiety and depression than the healthy controls. This is not surprising since patients with chronic headaches or pain of any kind are also more likely to be anxious and depressed. This does not mean that the pain is a manifestation of depression, as suggested by the authors.

A more interesting study of BMS in the same issue of Headache was published by Brazilian doctors. They treated 26 patients with mechanical stimulation of their mouth in order to increase the flow of saliva. This was achieved by having patients chew on a rubbery stick for ten minutes three times a day for 90 days. This resulted in a significant reduction of pain, even though the amount of saliva produced did not increase. In addition to improvement in pain, they also had fewer burning sites in the mouth and their taste improved as well.

Another approached that has been used to increase the flow of saliva reported in the medical literature is to stimulate salivary gland with a transcutaneous electrical nerve stimulation (TENS). The TENS electrodes are applied to the skin over the parotid salivary glands. There has been no reports of using TENS for the treatment of BMS, but considering that it is a safe and inexpensive treatment, it may be worth a try.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe